Why I’d buy GSK shares and this secret dividend stock for my ISA today

The GSK share price has risen by 15% so far in 2019. Roland Head explains why he remains a buyer.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

UK investors are very lucky when it comes to tax, in my opinion. Unless you are in a position to save more than £20,000 each year, you can put all your investments in a tax-free Stocks and Shares ISA.

This enables you to enjoy all the benefits of stock market investing without any future capital gains or income tax liability. And unlike pensions, there are no restrictions on withdrawals from an ISA.

It’s a fantastic system, I think. Today I want to look at two stocks I own that I think are ideal for long-term ISA holdings.

A 50% return in five years

Shareholders may argue that the GlaxoSmithKline (LSE: GSK) share price has been a disappointing performer over the last 20 years. And it’s true that the share price today is virtually the same as it was in October 1999.

However, investors who’ve bought within the last 10 years should mostly be in profit.

And in any case, I think that focusing on the share price alone is a mistake – Glaxo is a high-yield stock. If we include dividend payments, this pharma giant has delivered a shareholder return of 51% over the last five years alone. I think that’s very attractive.

An exciting future

GSK’s conglomerate structure combines consumer brands like Nicorette, Panadol, and Sensodyne with prescription medicines, vaccines, and specialist treatments for cancer and HIV.

Critics say that this broad focus actually results in a lack of focus, with successful units subsidising less successful activities. They argue that the group could deliver more growth – and boost shareholder returns – by splitting itself into separate pharmaceutical and consumer businesses.

Chief executive Emma Walmsley has been converted to this view and the group is gradually being prepared for a split. Existing shareholders are expected to receive shares in the new company, so will be able to choose whether they want to hold one, the other, or both.

The GSK share price has performed strongly over the last year and isn’t as cheap as it was. But the stock still offers a market-beating 4.6% yield and I think the split is likely to create a consumer business that’s valued strongly by the market.

In my view, Glaxo shares remain a good long-term buy for investors wanting a mix of income and growth.

My secret dividend stock

The next company I want to consider is one you may not be familiar with. Bloomsbury Publishing (LSE: BMY) is probably best known as the publisher of the Harry Potter books, plus a range of cookery and lifestyle titles.

The group also has a non-consumer division, but there’s no doubt that consumers are a big deal for this £195m firm. Last year, about 85% of profits came in the second half of the year, which includes Christmas.

In a half-year update today, Bloomsbury said it was confident that full-year results would be in line with expectations. That puts the stock on about 15 times forecast earnings, with a 3.3% dividend yield.

That may not seem cheap, but I rate this as a quality, specialist business. Cash generation is very strong and net cash has risen by 15% to £20.1m over the last year. This year’s dividend should be covered twice by earnings, and the payout has not been cut for 25 years.

I remain happy to hold the shares, which I rate as a long-term buy.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of Bloomsbury Publishing and GlaxoSmithKline. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Illustration of flames over a black background
Investing Articles

2 red-hot UK growth stocks to consider buying in April

These two growth stocks are performing well, but can they continue to deliver for investors through 2024 and beyond?

Read more »

Charticle

Is JD Sports Fashion one of the FTSE 100’s best value stocks? Here’s what the charts say!

The JD Sports Fashion share price remains a wild ride during the first quarter. Could it be one of the…

Read more »

Investing Articles

Could the JD Sports Fashion share price double in the next five years?

The JD Sports Fashion share price has nearly halved in the past five years. Our writer thinks a proven business…

Read more »

Bus waiting in front of the London Stock Exchange on a sunny day.
Investing Articles

If interest rate cuts are coming, I think these UK growth stocks could soar!

Falling interest could be great news for UK growth stocks, especially those that have been under the cosh recently. Paul…

Read more »

Investing Articles

Are these the best stocks to buy on the FTSE right now?

With the UK stock market on the way to hitting new highs, this Fool is considering which are the best…

Read more »

Petrochemical engineer working at night with digital tablet inside oil and gas refinery plant
Investing Articles

Can the Centrica dividend keep on growing?

Christopher Ruane considers some positive factors that might see continued growth in the Centrica dividend -- as well as some…

Read more »

Smiling family of four enjoying breakfast at sunrise while camping
Investing Articles

How I’d turn my £12,000 of savings into passive income of £1,275 a month

This Fool is considering a strategy that he believes can help him achieve a stable passive income stream with a…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

2 top FTSE 250 investment trusts trading at attractive discounts!

This pair of discounted FTSE 250 trusts appear to be on sale right now. Here's why I'd scoop up their…

Read more »